New Member Alert: RAAP WELCOMES BRISTOL MYERS SQUIBB! BMS Joins as Newest Member of RAAP

{
  "signal_id": "402e1ae7-cd62-5fec-31c0-27c540ee0ce5",
  "signal_type": "news",
  "signal_subtype": "partners_with",
  "detected_at": "2026-09-23T14:01:00+00:00",
  "company": {
    "name": "Bristol Myers Squibb",
    "domain": "bms.com"
  },
  "data": {
    "url": "https://www.prnewswire.com/news-releases/new-member-alert-raap-welcomes-bristol-myers-squibb-bms-joins-as-newest-member-of-raap-302886640.html",
    "title": "New Member Alert: RAAP WELCOMES BRISTOL MYERS SQUIBB! BMS Joins as Newest Member of RAAP",
    "excerpt": "WASHINGTON , Sept. 23, 2026 /PRNewswire/ -- The Rare Access Action Project (RAAP) announced today that Bristol Myers Squibb (BMS) has joined RAAP as its newest member, expanding the coalition of patient and life sciences stakeholders working together to address access and coverage challenges affecting people living with rare diseases. \"We are pleased to welcome Bristol Myers Squibb to the Rare Access Action Project,\" said Michael Eging, Executive Director of RAAP. \"BMS brings a long history of scientific innovation and a strong commitment to patients facing serious and complex diseases. Their participation will add an important perspective to our work as we seek practical policy solutions that protect patient access to innovative treatments and care.\" Bristol Myers Squibb is a global biopharmaceutical company focused on discovering, developing and delivering innovative medicines for patients with serious diseases. The company's core therapeutic areas include oncology, hematology, immunology, cardiovascular disease and neuroscience. Through scientific research and collaboration, BMS works to advance transformational medicines and improve outcomes for patients around the world. \"Patients living with rare and serious diseases often face significant challenges in accessing the treatments and care they need,\" said Mary Bordoni, Executive Director, Alliance Development, Bristol...",
    "summary": "Bristol Myers Squibb has joined the Rare Access Action Project (RAAP) as its newest member.",
    "location": "Washington, D.C., USA",
    "planning": false,
    "image_url": "https://mmx.prnewswire.com/media/MS1199381/RAAPR-FINAL-Logo.jpg?id=OA2963508&p=facebook",
    "confidence": 0.9,
    "published_at": "2026-09-23T14:01:00Z",
    "location_data": [
      {
        "city": "Washington",
        "state": "District of Columbia",
        "region": "Northern America",
        "country": "United States",
        "continent": "Americas",
        "fuzzy_match": false
      }
    ],
    "effective_date": "2026-09-23",
    "article_sentence": "The Rare Access Action Project (RAAP) announced today that Bristol Myers Squibb (BMS) has joined RAAP as its newest member, expanding the coalition of patient and life sciences stakeholders working together to address access and coverage challenges affecting people living with rare diseases.",
    "related_company_name": "Rare Access Action Project",
    "related_company_domain": "rareaccessactionproject.org"
  }
}

curl https://signals.autobound.ai/v1/signals/402e1ae7-cd62-5fec-31c0-27c540ee0ce5 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"bms.com","limit":20}'